Cipla, the country’s third-largest drug maker has acquired the exclusive rights to market skin care products of a derma and cosmeceutical player Percos India, in a deal worth an estimated 90 crore, reports ET..IndusLaw acted for Cipla and the team included Partner Nishant Singh, Associates Vaibhav Ganjiwale, Ramya Sridhar and Chhavi Jhanji with support from Senior Associate Aditi Verma Thakur on IP issues..N South Law Associates acted for Percos India with a team led by Partner Inderraj Gill..Brands from Percos will help shore up Cipla’s dermatology portfolio with an expanded offering into cosmetology, a business segment that is thriving for the last few years. Cipla will bag a few fast growing brands like Vedaderm, Claz, Actipeel, Tryses and Glycoveda, which have combined sales of around 10 crore, according to ET.
Cipla, the country’s third-largest drug maker has acquired the exclusive rights to market skin care products of a derma and cosmeceutical player Percos India, in a deal worth an estimated 90 crore, reports ET..IndusLaw acted for Cipla and the team included Partner Nishant Singh, Associates Vaibhav Ganjiwale, Ramya Sridhar and Chhavi Jhanji with support from Senior Associate Aditi Verma Thakur on IP issues..N South Law Associates acted for Percos India with a team led by Partner Inderraj Gill..Brands from Percos will help shore up Cipla’s dermatology portfolio with an expanded offering into cosmetology, a business segment that is thriving for the last few years. Cipla will bag a few fast growing brands like Vedaderm, Claz, Actipeel, Tryses and Glycoveda, which have combined sales of around 10 crore, according to ET.